PATENT CLAIM ANALYSIS

Application Number: 15742087
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "139100"]

Abstract:
The present invention relates to Tau-binding antibodies and binding fragments thereof.

Claim (Index 21):
An isolated Tau-binding antibody or binding fragment thereof, wherein said Tau-binding antibody or binding fragment thereof comprises:\n a light chain variable region comprising a CDR1 selected from SEQ ID NO: 1, a CDR2 selected from SEQ ID NO: 2, and a CDR3 selected from SEQ ID NO: 3; and a heavy chain variable region comprising a CDR1 selected from SEQ ID NO: 4, a CDR2 selected from SEQ ID NO: 5, and/or a CDR3 selected from SEQ ID NO: 6.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15742070', '14654176', '13271118', '15257086', '14532531']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.74315933412652
- 35 USC 102 Novelty (BERT): 0.6080177503581916
- Combined Prediction Score: 0.7296451757496872
- Mean Citation Score: 441.577828
- Max Citation Score: 534.597
- Similarity Product: 488.83660216552016

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test